Early research (Phase 1)Study completedNCT05398796
What this trial is testing
Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults
Who this might be right for
Nipah Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 40